Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation

Nafamostat, a serine proteinase inhibitor with various actions including antithrombin, antiplasmin, and antitrypsin effects, has been used in clinical practice to treat disseminated intravascular coagulation (DIC) and pancreatitis. This case report describes the clinical course of a patient with COV...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Infect Dis
Principais autores: Takahashi, Wakana, Yoneda, Taro, Koba, Hayato, Ueda, Tsukasa, Tsuji, Noriaki, Ogawa, Haruhiko, Asakura, Hidesaku
Formato: Artigo
Idioma:Inglês
Publicado em: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7607231/
https://ncbi.nlm.nih.gov/pubmed/33157292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.10.093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados